Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950137-04-004136
Filing Date
2004-05-14
Accepted
2004-05-14 17:16:14
Documents
8
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT c85567e10vq.htm 10-Q 232260
2 WAIVER AND NOTIFICATION OF BANK COVENANTS c85567exv10w1.htm EX-10.1 3842
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c85567exv31w1.htm EX-31.1 4903
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER c85567exv31w2.htm EX-31.2 4906
5 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c85567exv32w1.htm EX-32.1 2237
6 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER c85567exv32w2.htm EX-32.2 2475
7 GRAPHIC c85567c8556700.gif GRAPHIC 4046
8 GRAPHIC c85567c8556701.gif GRAPHIC 4236
  Complete submission text file 0000950137-04-004136.txt   261369
Mailing Address 100 TRI STATE INTERNATIONAL SUITE 100 LINCOLNSHIRE IL 60069
Business Address 2500 MILLBROOK DRIVE BUFFALO GROVE IL 60089 8472796100
AKORN INC (Filer) CIK: 0000003116 (see all company filings)

EIN.: 720717400 | State of Incorp.: LA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13976 | Film No.: 04808860
SIC: 2834 Pharmaceutical Preparations